BIAF News
Archived Headlines
- US IPO Week Ahead: 1 small IPO in another quiet week 07/29/22
- bioAffinity Technologies cuts deal size by 30% ahead of $7 million unit offering 07/28/22
- Lung cancer diagnostics developer bioAffinity Technologies sets terms for $10 million IPO, now offering units 05/25/22
- Lung cancer diagnostics developer bioAffinity Technologies files for a $15 million IPO 04/25/22
US IPO Weekly Recap: Summer IPO market ends with more small deals
The long Labor Day weekend is here, which means the summer IPO market has come to an end. Four small issuers began trading this past week, although only two met our tracking criteria. Just two IPOs and one SPAC submitted initial filings. The most notable news...read more
Lung cancer diagnostics developer bioAffinity Technologies prices IPO at $6.13 midpoint
bioAffinity Technologies, which is developing a noninvasive test for early detection of lung cancer, raised $8 million by offering 1.3 million units at $6.13, the midpoint of the range of $6 to $6.25. Insiders had indicated on 8% of units in the...read more
US IPO Week Ahead: Hemp cigarette micro-cap to debut as August IPO market closes out
As August comes to an end, the US IPO market looks to close out the month with three small deals, though only one meets our tracking criteria. Other small deals may also join the calendar during the week. Hemp cigarette manufacturer Hempacco...read more
Lung cancer diagnostics developer bioAffinity Technologies increases deal size by 11% ahead of $8 million unit offering
bioAffinity Technologies, which is developing a noninvasive test for early detection of lung cancer, raised the proposed deal size for its upcoming IPO on Friday. The San Antonio, TX-based company now plans to raise $8 million by offering 1.3 million units at a...read more